https://stanfordhealthcare.org/publications/391/391843.html
391843 | Stanford Health Care
Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessm
stanfordhealthcare